Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C.
Hemodialysis patient with chronic HCV infection,who was started on monotherapy with interferon.Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72 weeks. HCV RNA negative six months after treatment.
Vigani
Aline Gonzalez
AG
Viral Hepatitis Study Group, Department of Medical Clinic, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, Brazil. aline.vigani@sigmanet.com.br
Pavan
Maria H P
MH
Tozzo
Raquel
R
Gonçales
Eduardo S L
ES
Lazarini
Maria S K
MS
Oliveira
Alexandre Macedo de
AM
Gonçales
Fernando L
FL
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D012367:RNA, Viral / Q000032:analysis; D006435:Renal Dialysis; D012254:Ribavirin / Q000008:administration & dosage*; D016896:Treatment Outcome
D000998:Antiviral Agents; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons